Targeted delivery of CXCR4-siRNA by scFv for HER2(+) breast cancer therapy.
Jiang K, Li J, Yin J, Ma Q, Yan B, Zhang X, Wang L, Wang L, Liu T, Zhang Y, Fan Q, Yang A, Qiu X, Ma B.
Jiang K, et al.
Biomaterials. 2015 Aug;59:77-87. doi: 10.1016/j.biomaterials.2015.04.030. Epub 2015 May 15.
Biomaterials. 2015.
PMID: 25956853